Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Frett

Showing results (11-20 of 54) with videos related to

Pageof 6
Sort By:
European Journal of Medicinal Chemistry|September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluationBrendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
The AAPS Journal|December 20, 2019
Structural Characterization of the Aurora Kinase B "DFG-flip" Using MetadynamicsNaga Rajiv Lakkaniga, Meenakshisundaram Balasubramaniam, Shuxing Zhang, et al.
Medchemcomm|February 5, 2016
Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studiesBrendan Frett, Nick McConnell, Yuanxiang Wang, et al.
Chemistryselect|August 25, 2018
Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo ActivityNicholas McConnell, Zhigang Xu, Vishnu Kumarasamy, et al.
Chemmedchem|February 9, 2021
Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization ApproachDebasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, et al.
Journal of Medicinal Chemistry|September 25, 2019
The Exploration of Chirality for Improved Druggability within the Human KinomeDebasmita Saha, Anupreet Kharbanda, Wei Yan, et al.
Journal of Medicinal Chemistry|February 13, 2014
Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibitionBrendan Frett, Robert V Brown, Mingliang Ma, et al.
European Journal of Medicinal Chemistry|September 18, 2025
Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitorsBaku Acharya, Maha Hanafi, Luke Enemark, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
European Journal of Medicinal Chemistry|July 28, 2020
Discovery of SP-96, the first non-ATP-competitive Aurora Kinase B inhibitor, for reduced myelosuppressionNaga Rajiv Lakkaniga, Lingtian Zhang, Binyam Belachew, et al.
Pageof 6

Showing results (11-20 of 54) with videos related to

Sort By:
Pageof 6
European Journal of Medicinal Chemistry|September 19, 2014
Identification of two novel RET kinase inhibitors through MCR-based drug discovery: design, synthesis and evaluationBrendan Frett, Marialuisa Moccia, Francesca Carlomagno, et al.
The AAPS Journal|December 20, 2019
Structural Characterization of the Aurora Kinase B "DFG-flip" Using MetadynamicsNaga Rajiv Lakkaniga, Meenakshisundaram Balasubramaniam, Shuxing Zhang, et al.
Medchemcomm|February 5, 2016
Identification of pyrazine-based TrkA inhibitors: design, synthesis, evaluation, and computational modeling studiesBrendan Frett, Nick McConnell, Yuanxiang Wang, et al.
Chemistryselect|August 25, 2018
Synthesis of Constrained Heterocycles Employing Two Post-Ugi Cyclization Methods for Rapid Library Generation with In Cellulo ActivityNicholas McConnell, Zhigang Xu, Vishnu Kumarasamy, et al.
Chemmedchem|February 9, 2021
Pyrazoloadenine Inhibitors of the RET Lung Cancer Oncoprotein Discovered by a Fragment Optimization ApproachDebasmita Saha, Katie Rose Ryan, Naga Rajiv Lakkaniga, et al.
Journal of Medicinal Chemistry|September 25, 2019
The Exploration of Chirality for Improved Druggability within the Human KinomeDebasmita Saha, Anupreet Kharbanda, Wei Yan, et al.
Journal of Medicinal Chemistry|February 13, 2014
Therapeutic melting pot of never in mitosis gene a related kinase 2 (Nek2): a perspective on Nek2 as an oncology target and recent advancements in Nek2 small molecule inhibitionBrendan Frett, Robert V Brown, Mingliang Ma, et al.
European Journal of Medicinal Chemistry|September 18, 2025
Discovery of novel 1H-pyrazolo[3,4-d]pyrimidine derivatives as BRK/PTK6 inhibitorsBaku Acharya, Maha Hanafi, Luke Enemark, et al.
European Journal of Medicinal Chemistry|August 22, 2021
Discovery of 4-aminoquinolines as highly selective TGFβR1 inhibitors with an attenuated MAP4K4 profile for potential applications in immuno-oncologyAnupreet Kharbanda, Phuc Tran, Lingtian Zhang, et al.
European Journal of Medicinal Chemistry|July 28, 2020
Discovery of SP-96, the first non-ATP-competitive Aurora Kinase B inhibitor, for reduced myelosuppressionNaga Rajiv Lakkaniga, Lingtian Zhang, Binyam Belachew, et al.
Pageof 6